Insulin therapy and cancer

doi:10.2337/dcS13-2002

Review

. 2013 Aug;36 Suppl 2(Suppl 2):S240-4.

doi: 10.2337/dcS13-2002.

Insulin therapy and cancer

Philip Home¹

Affiliations

PMID: 23882052
PMCID: PMC3920801
DOI: 10.2337/dcS13-2002

Review

Insulin therapy and cancer

Philip Home. Diabetes Care. 2013 Aug.

. 2013 Aug;36 Suppl 2(Suppl 2):S240-4.

doi: 10.2337/dcS13-2002.

Author

Philip Home¹

Affiliation

¹ Institute of Cellular Medicine-Diabetes, Newcastle University, Newcastle upon Tyne, UK. philip.home@ncl.ac.uk

PMID: 23882052
PMCID: PMC3920801
DOI: 10.2337/dcS13-2002

No abstract available

PubMed Disclaimer

Cited by

Nanomicellar Formulation of Clotrimazole Improves Its Antitumor Action toward Human Breast Cancer Cells.
Marcondes MC, Fernandes AC, Itabaiana I Jr, de Souza RO, Sola-Penna M, Zancan P. Marcondes MC, et al. PLoS One. 2015 Jun 22;10(6):e0130555. doi: 10.1371/journal.pone.0130555. eCollection 2015. PLoS One. 2015. PMID: 26098874 Free PMC article.
Insulin glargine use and breast cancer risk: Associations with cumulative exposure.
Peeters PJ, Bazelier MT, Leufkens HG, Auvinen A, van Staa TP, de Vries F, De Bruin ML. Peeters PJ, et al. Acta Oncol. 2016 Jul;55(7):851-8. doi: 10.3109/0284186X.2016.1155736. Epub 2016 May 6. Acta Oncol. 2016. PMID: 27150973 Free PMC article.
Anti-Diabetic Drugs: Cure or Risk Factors for Cancer?
Laskar J, Bhattacharjee K, Sengupta M, Choudhury Y. Laskar J, et al. Pathol Oncol Res. 2018 Oct;24(4):745-755. doi: 10.1007/s12253-018-0402-z. Epub 2018 Mar 13. Pathol Oncol Res. 2018. PMID: 29536373 Review.
Targeting Adipokines in Obesity-Related Tumors.
Pu X, Chen D. Pu X, et al. Front Oncol. 2021 Aug 4;11:685923. doi: 10.3389/fonc.2021.685923. eCollection 2021. Front Oncol. 2021. PMID: 34485124 Free PMC article. Review.
Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.
Bronsveld HK, ter Braak B, Karlstad Ø, Vestergaard P, Starup-Linde J, Bazelier MT, De Bruin ML, de Boer A, Siezen CL, van de Water B, van der Laan JW, Schmidt MK. Bronsveld HK, et al. Breast Cancer Res. 2015 Aug 5;17(1):100. doi: 10.1186/s13058-015-0611-2. Breast Cancer Res. 2015. PMID: 26242987 Free PMC article.

See all "Cited by" articles

References

1. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care 2010;33:1674–1685 - PMC - PubMed
1. Yang X-L, Chan JCN. Diabetes, insulin and cancer risk. World J Diabetes 2012;3:60–64 - PMC - PubMed
1. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97:1679–1687 - PubMed
1. Oleksiewicz MB, Southgate J, Iversen L, Egerod FL. Rat urinary bladder carcinogenesis by dual-acting PPARalpha + gamma agonists. PPAR Res 2008;2008:103167. - PMC - PubMed
1. Dormandy J, Bhattacharya M, van Troostenburg de Bruyn A-R, PROactive investigators Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive. Drug Saf 2009;32:187–202 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care 2010;33:1674–1685 - PMC - PubMed

[2] Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care 2010;33:1674–1685 - PMC - PubMed

[3] Yang X-L, Chan JCN. Diabetes, insulin and cancer risk. World J Diabetes 2012;3:60–64 - PMC - PubMed

[4] Yang X-L, Chan JCN. Diabetes, insulin and cancer risk. World J Diabetes 2012;3:60–64 - PMC - PubMed

[5] Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97:1679–1687 - PubMed

[6] Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97:1679–1687 - PubMed

[7] Oleksiewicz MB, Southgate J, Iversen L, Egerod FL. Rat urinary bladder carcinogenesis by dual-acting PPARalpha + gamma agonists. PPAR Res 2008;2008:103167. - PMC - PubMed

[8] Oleksiewicz MB, Southgate J, Iversen L, Egerod FL. Rat urinary bladder carcinogenesis by dual-acting PPARalpha + gamma agonists. PPAR Res 2008;2008:103167. - PMC - PubMed

[9] Dormandy J, Bhattacharya M, van Troostenburg de Bruyn A-R, PROactive investigators Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive. Drug Saf 2009;32:187–202 - PubMed

[10] Dormandy J, Bhattacharya M, van Troostenburg de Bruyn A-R, PROactive investigators Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive. Drug Saf 2009;32:187–202 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Insulin therapy and cancer

Affiliation

Insulin therapy and cancer

Author

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical